deltatrials

Gastroesophageal reflux Trials in Rochester, United States

Conditions / Gastroesophageal reflux / Rochester, United States

Research into Gastroesophageal reflux spans multiple therapeutic approaches and trial phases.

10 total trials for this combination

Trials

NCT ID Title Status Phase
NCT05343364 A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease COMPLETED PHASE1
NCT00246909 Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) COMPLETED PHASE4
NCT00776997 LINX Reflux Management System Clinical Study Protocol COMPLETED NA
NCT02776982 Influence of Central Obesity on the Esophageal Epithelial Barrier COMPLETED NA
NCT04411823 Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction RECRUITING NA
NCT00170001 Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy COMPLETED NA
NCT03005080 Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease COMPLETED
NCT00847808 Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy COMPLETED PHASE3
NCT02708303 Mayo Clinic Foregut Surgery Report Card Questionnaire TERMINATED
NCT00624546 Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD TERMINATED

Related Pages